Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.
Clinical trial NCT02140411 · COMPLETED
Trial details
- NCT number
- NCT02140411
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-25
- Primary completion
- 2016-12-21
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.